Characteristics and Maternal and Birth Outcomes of Hospitalized

This report describes clinical characteristics and birth outcomes of hospitalized U.S. pregnant women with COVID-19 during March 1–August 22, 2020.

Trends and Disparities in Delivery Hospitalizations Involving

Maternal morbidities and outcomes in pregnant women with COVID-19

Coronavirus disease 2019 in pregnancy was associated with maternal

COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022

Viral Infections During Pregnancy: The Big Challenge Threatening Maternal and Fetal Health

Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults

Vaccines, Free Full-Text

Frontiers Trends in the Incidence and Risk Factors of Pregnancy

2 Contributors to and Trends in Morbidity, Mortality, and

Management of Pregnant Women With COVID-19 Infection Proves Complex

Managing maternity costs and outcomes: Improving costs and

Preterm Birth in the United States: Exploring Disparities

First- or second-trimester SARS-CoV-2 infection and subsequent pregnancy outcomes - American Journal of Obstetrics & Gynecology

JCI - Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine